Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal
about
The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseasesOxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Age-related changes in mitochondrial respiration and oxidative damage in the cerebral cortex of the Fischer 344 rat.The synthesis and characterization of cellular membrane affinity chromatography columns for the study of human multidrug resistant proteins MRP1, MRP2 and human breast cancer resistant protein BCRP using membranes obtained from Spodoptera frugiperdaAge-related mitochondrial changes after traumatic brain injuryMultidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle.Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1).Interactions of glutathione transferases with 4-hydroxynonenal.Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver diseaseThe G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenalLoss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null miceImplications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance.Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.Physiological and pharmacological significance of glutathione-conjugate transport.Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.Mrp1 localization and function in cardiac mitochondria after doxorubicin.Inflammation, reactive oxygen species and cytochrome P450.Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.Increased expression of the multidrug resistance-associated protein 1 (MRP1) in kidney glomeruli of streptozotocin-induced diabetic rats.
P2860
Q26822972-F2414A99-05E7-4790-8C2F-B522FB49A148Q33639885-F38C7E10-DD98-47F8-8145-BB54013B8625Q33709605-2836E85B-0292-422E-9E24-A10E78CB44DFQ33833252-1C024EFF-FD9E-4031-98A5-9C00C46C8053Q34147870-6AD8ED83-B73B-4084-81BE-2D6F03FFAE4FQ34467407-872ECE19-F724-451A-9B39-16198FE373B8Q35444762-ADE1C4B8-8C45-49E4-8C65-95CBA28589F0Q35565558-362C60C9-7F59-499A-A076-E7E8B65A506DQ35731685-C8E689C1-A6D8-4409-886B-0620C59FE5F0Q35792208-974F4FB3-818A-4C0D-9832-46E186CB0776Q35840905-0EA99750-FE67-456C-843B-1D7857F2DCCCQ36186168-574FA666-EBFA-4ED3-99D8-2D092F27B9BEQ36186203-115846C7-19EF-4B27-ACDA-9AA8D1F03CDBQ36565671-AB54AF26-370A-4B87-9A65-5686BC009821Q36588606-0619B620-AEE0-4AB8-852A-D79CB8D87157Q37291393-F5A6B4DE-D224-4252-8943-63D454C37172Q37698426-2C002E09-14E0-45F8-AFA9-45ED69B36BE0Q38958745-A2541D49-8F6A-498A-9A50-F1A4E0B11579Q43141751-76C46677-9EBB-4749-8ECD-0A6D1685361AQ44808645-CD949C7C-6001-441F-9803-5C85462123A1Q46646341-19DF6443-E4C7-4F5B-8871-3BF16C09A1AFQ46725859-58847B68-E6FD-4FCE-9DB7-02C06DBF0B61Q54377796-823F5DE9-4340-4EB8-A9C3-739758808C86
P2860
Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Multidrug resistance protein M ...... ation product 4-hydroxynonenal
@en
type
label
Multidrug resistance protein M ...... ation product 4-hydroxynonenal
@en
prefLabel
Multidrug resistance protein M ...... ation product 4-hydroxynonenal
@en
P2093
P2860
P1433
P1476
Multidrug resistance protein M ...... ation product 4-hydroxynonenal
@en
P2093
P2860
P304
P356
10.1042/0264-6021:3500555
P407
P478
P577
2000-09-01T00:00:00Z